AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 173 filers reported holding AGIOS PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 0.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $516,320 | -98.1% | 17,658 | -94.9% | 0.01% | -99.1% |
| Q3 2018 | $26,853,000 | -8.9% | 348,200 | -0.5% | 0.96% | -7.1% |
| Q2 2018 | $29,481,000 | -1.5% | 350,000 | -4.4% | 1.04% | -0.2% |
| Q1 2018 | $29,931,000 | +99.1% | 366,000 | +39.2% | 1.04% | +75.2% |
| Q4 2017 | $15,035,000 | +8.3% | 262,984 | +26.4% | 0.59% | -5.3% |
| Q3 2017 | $13,884,000 | +228.8% | 208,000 | +37.7% | 0.62% | +218.9% |
| Q3 2013 | $4,223,000 | – | 151,050 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Caligan Partners LP | 514,711 | $22,194,338 | 5.19% |
| ACUTA CAPITAL PARTNERS, LLC | 78,700 | $3,393,544 | 2.86% |
| Bellevue Group AG | 3,879,548 | $167,286,110 | 2.72% |
| Parkman Healthcare Partners LLC | 446,416 | $19,249,458 | 2.58% |
| Eagle Health Investments LP | 330,830 | $14,265,390 | 2.50% |
| SECTOR GAMMA AS | 121,844 | $5,253,913 | 1.96% |
| Frazier Life Sciences Management, L.P. | 871,974 | $37,599,519 | 1.76% |
| BVF INC/IL | 1,190,107 | $51,317,414 | 1.44% |
| Rock Springs Capital Management LP | 1,044,261 | $45,028,534 | 1.36% |
| FARALLON CAPITAL MANAGEMENT LLC | 5,654,502 | $243,822,126 | 1.15% |